Dr. Shadduck studies how different treatments and environmental factors affect blood cell formation and function. One area he focuses on is myelodysplastic syndrome, a condition where the bone marrow doesn't produce enough healthy blood cells. He tests combinations of drugs, like pentoxifylline and ciprofloxacin, to see if they can improve blood cell counts in patients. Additionally, he explores how exposure to radiation can increase the risk of leukemia by affecting bone marrow cells, which is crucial for developing preventative strategies and effective treatments for patients who have been exposed to radiation.
Key findings
In a phase II trial, the combination of pentoxifylline and ciprofloxacin was tested in 14 patients with myelodysplastic syndrome, but showed no significant change in blood cell counts or inflammatory markers.
Gamma radiation exposure during experiments led to a 60-fold increase in abnormal cell clusters and cancerous cell lines from bone marrow cells, highlighting a potential link between radiation and leukemia risk.
The study of a murine adherent marrow cell line showed it could stimulate the growth of blood cells in combination with interleukin 3 (IL 3), providing insights into blood disorder treatments.
Irradiated bone marrow cells increased the growth of blood cell lines by over 30 times and resulted in 1000 times more growth-independent cells after 15 weeks, suggesting new avenues for blood disorder therapies.
Frequently asked questions
Does Dr. Shadduck study myelodysplastic syndrome?
Yes, he investigates potential treatments for myelodysplastic syndrome, focusing on drug combinations that may help improve blood cell counts.
What risks associated with radiation does Dr. Shadduck research?
He studies how radiation exposure can increase the risk of developing leukemia by affecting bone marrow cells' behavior.
Is Dr. Shadduck's work relevant for patients with blood disorders?
Yes, his research is directly relevant to patients with various blood disorders as he seeks to improve treatments and understand the mechanisms behind these conditions.
What treatments has Dr. Shadduck investigated?
He has researched drug combinations like pentoxifylline and ciprofloxacin and has also looked into how certain bone marrow cells can be manipulated to improve treatment outcomes for blood disorders.
Publications in plain English
Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial.
1995
American journal of clinical oncology
Nemunaitis J, Rosenfeld C, Getty L, Boegel F, Meyer W +3 more
Plain English This study tested the combination of two drugs, pentoxifylline and ciprofloxacin, in 14 patients with myelodysplastic syndrome to see if they could improve blood cell counts and reduce inflammation. While the drugs were generally well tolerated, causing nausea in just four patients, there was no significant change in blood cell counts or levels of important inflammatory markers during treatment. This matters because finding effective treatments for myelodysplastic syndrome is crucial, but this particular combination did not show effectiveness.
Who this helps: Patients with myelodysplastic syndrome.
Humoral and cell surface interactions during gamma-irradiation leukemogenesis in vitro.
1992
Experimental hematology
Greenberger J, Leif J, Crawford D, Anklesaria P, English D +5 more
Plain English This study looked at how gamma radiation affects specific types of bone marrow cells and their ability to develop into leukemia. Researchers found that when certain bone marrow cells were exposed to radiation and then grown together with other cell types, there was a 60-fold increase in the formation of abnormal cell clusters and cancerous cell lines that no longer needed growth factors to thrive. This finding is important because it helps explain how radiation might increase the risk of leukemia, potentially impacting treatment approaches for patients exposed to radiation.
Who this helps: This helps patients who may be at risk for leukemia after radiation exposure and their healthcare providers.
Multilineage synergistic activity produced by a murine adherent marrow cell line.
1987
Blood
Quesenberry P, Song ZX, McGrath E, McNiece I, Shadduck R +4 more
Plain English In this research, scientists studied a specific type of cell line called TC-1, derived from bone marrow, to see how it helps produce different blood cells. They found that TC-1 produces a substance that works together with another protein called interleukin 3 (IL 3) to stimulate the growth of various blood cell types, including giant macrophages and pre-B cells. This is important because understanding how these cells develop can provide insights into blood disorders and improve treatments.
Who this helps: This research benefits patients with blood-related conditions and healthcare providers looking for better therapies.
Induction of growth alterations in factor-dependent hematopoietic progenitor cell lines by cocultivation with irradiated bone marrow stromal cell lines.
1986
Blood
Naparstek E, Pierce J, Metcalf D, Shadduck R, Ihle J +5 more
Plain English Researchers investigated how certain bone marrow cells, when exposed to radiation, affect the growth of other blood cell-producing cells. They found that irradiated bone marrow cells significantly increased the growth of specific blood cell lines by over 30 times and changed those cells to become less reliant on growth factors for survival, with over 1000 times more of these growth-independent cells after 15 weeks. This is important because it shows how radiation can alter the behavior of cells in ways that could help develop new treatments for blood disorders or cancers.
Who this helps: This research benefits patients with blood-related diseases and doctors looking for new treatment strategies.